Voyager Therapeutics (VYGR) Receivables - Other (2019 - 2026)

Voyager Therapeutics has disclosed Receivables - Other across 8 years of filings, most recently posting $222000.0 for Q2 2026.

• In Q2 2026, Receivables - Other fell 73.91% year-over-year to $222000.0; the TTM figure through Jun 2026 stood at $222000.0 (down 73.91% YoY), while the FY2025 annual figure was $151000.0, down 77.66% from the prior year.
• Receivables - Other came in at $222000.0 for Q2 2026 at Voyager Therapeutics, up from $151000.0 in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $3.7 million in Q3 2024 to a low of $151000.0 in Q2 2022.
• Average Receivables - Other over 5 years is $1.2 million, with a median of $581500.0 recorded in 2024.
• Year-over-year, Receivables - Other slumped 95.16% in 2022 and jumped 2118.54% in 2023.
• Over 5 years, Receivables - Other stood at $257000.0 in 2022, then jumped by 1200.0% to $3.3 million in 2023, then sank by 79.77% to $676000.0 in 2024, then sank by 77.66% to $151000.0 in 2025, then soared by 47.02% to $222000.0 in 2026.
• Per Business Quant data, the three most recent Receivables - Other figures were $222000.0 in Q2 2026, $151000.0 in Q1 2026, and $151000.0 in Q4 2025.